OncoImmunology
Volume 9, 2020 - Issue 1
Review
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
, , , , , , , 
, , & show all
Laurence Zitvogelh Gustave Roussy Comprehensive Cancer Institute, Villejuif, France;i INSERM, U1015, Villejuif, France;j Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France;k Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, Francehttps://orcid.org/0000-0003-1596-0998
https://orcid.org/0000-0003-1596-0998, Guido Kroemerl Equipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, Université de Paris, Sorbonne Université, INSERM U1138, Paris, France;m Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France;n Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;o Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China;p Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, Swedenhttps://orcid.org/0000-0002-9334-4405
https://orcid.org/0000-0002-9334-4405, Lorenzo Galluzziq Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA;r Sandra and Edward Meyer Cancer Center, New York, NY, USA;s Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA;t Department of Dermatology, Yale School of Medicine, New Haven, CT, USA;u Université de Paris, Paris, FranceCorrespondence[email protected]
https://orcid.org/0000-0003-2257-8500
https://orcid.org/0000-0003-2257-8500 & Abhishek D. Garga Cell Death Research & Therapy (CDRT) unit, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0002-9976-9922
https://orcid.org/0000-0002-9976-9922 show all